AUG 05, 2021 9:35 AM PDT

Brain's Version of THC Reduces Seizures, Increases Side Effects

WRITTEN BY: Annie Lennon

An endocannabinoid similar to tetrahydrocannabinol (THC) that naturally occurs in the brain reduces seizure activity. However, it also fuels a prolonged stroke-like event in the brain. The corresponding study was published in Neuron by researchers from multiple institutions. 

Epileptic seizures are ‘electrical storms’ that usually begin in or near the hippocampus, a part of the brain that plays a significant role in short-term memory, learning, and spatial orientation. These electrical storms later spread throughout the brain, causing symptoms including convulsions and loss of consciousness. 

These seizures also trigger the rapid synthesis of an endocannabinoid called 2-arachidonoylglycerol, or 2-AG. Like THC, it has an affinity for a receptor known as CB1 that is extremely abundant in the brain. While it is known to reduce seizure intensity, it is also known to activate a series of biochemical reactions that result in blood vessel constriction in the brain and thus disorientation and amnesia. 

 

In experiments, the researchers used novel endocannabinoid visualization techniques to track sub-second changes in levels of 2-AG in the hippocampus during normal periods of activity such as running or walking and during brief induced seizures. 

In doing so, they found that several hundred times as much 2-AG was released during a seizure than normal activity and that previously undetected 2-AG activity alone reduced excitatory neurons’ excessive firing during seizures. 

However, they also found that 2-AG is almost immediately converted to arachidonic acid, a building block for a variety of prostaglandin that causes blood vessels to constrict, thus reducing oxygen supply to areas of the brain. 

“A drug that blocks 2-AG’s conversion to arachidonic acid would kill two birds with one stone,” said Ivan Soltesz, senior author of the study. “It would increase 2-AG’s concentration, diminishing seizure severity, and decrease arachidonic acid levels, cutting off the production of blood-vessel-constricting prostaglandins.”

 

Sources: NeuronNeuroscience News

About the Author
  • Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
MAY 02, 2021
Cannabis Sciences
Medical Cannabis for Epilepsy May Be Linked to Early Puberty
MAY 02, 2021
Medical Cannabis for Epilepsy May Be Linked to Early Puberty
Current research suggests that cannabidiol (CBD) oil may be effective in managing seizures in childhood-onset epilepsy. ...
MAY 04, 2021
Health & Medicine
Micro-dosing Inhaler Breakthrough for Medical Cannabis
MAY 04, 2021
Micro-dosing Inhaler Breakthrough for Medical Cannabis
In a leap that will eliminate the risks of vaping or smoking, Canada has just approved an Israeli-made inhaler that is a ...
MAY 25, 2021
Health & Medicine
Cannabis: Could it Help Chronic Itch?
MAY 25, 2021
Cannabis: Could it Help Chronic Itch?
Chronic itch —clinically known as chronic pruritus — is characterized as an unrelenting sensation to scratch ...
JUN 11, 2021
Cannabis Sciences
Does Cannabis Interact with the COVID Vaccine?
JUN 11, 2021
Does Cannabis Interact with the COVID Vaccine?
As of June 10th 2021, 43% of people in the US aged 12 and over have been fully vaccinated for COVID-19, with 5 ...
AUG 13, 2021
Health & Medicine
15% of Employees Have Worked From Home While High
AUG 13, 2021
15% of Employees Have Worked From Home While High
Working from home became a huge (and successful) trend during the pandemic, and even with communities now re-opening, ma ...
SEP 09, 2021
Health & Medicine
Cannabis and Pain Management- A Double Edged Sword?
SEP 09, 2021
Cannabis and Pain Management- A Double Edged Sword?
In 2016 it was estimated by the CDC that 20.4% of Americans have chronic pain. Chronic pain is a primary reaso ...
Loading Comments...